Minimum Offering. Each Buyer understands that the Company may accept such Buyer’s purchase hereunder, at any time once the Company shall have received an aggregate Purchase Price in the amount of $800,000. Any officer or director of the Company or the Placement Agent, or any of such parties affiliates, may participate in this offering and their investment, if any, will count towards the foregoing minimum amount. As such, Buyer understands that the Company may not receive proceeds hereunder in any amount greater than $800,000, which may limit the Company’s ability to execute upon its intended business plan.
Appears in 1 contract
Samples: Securities Purchase Agreement (ENDRA Life Sciences Inc.)
Minimum Offering. Each Buyer understands that the Company may accept such Buyer’s purchase hereunder, hereunder at any time once the Company shall have received an aggregate Purchase Price in the amount of at least $800,0004,000,000 or such other amount as may be agreed by the Company and the Placement Agent. Any officer or director of the Company or the Placement Agent, or any of such parties parties’ affiliates, may participate in this offering and their investment, if any, will count towards the foregoing minimum amount. As such, Buyer understands that the Company may not receive proceeds hereunder in any amount greater than $800,0004,000,000, which may limit the Company’s ability to execute upon its intended business plan.
Appears in 1 contract
Samples: Securities Purchase Agreement (ENDRA Life Sciences Inc.)
Minimum Offering. Each Buyer understands that the minimum purchase by any Buyer shall be $100,000, except that subscriptions for a lesser amount may be accepted in the discretion, and mutual agreement, of the Company and Placement Agent. Each Buyer further understands that the Company may accept such Buyer’s purchase hereunder, at any time once the Company shall have received an aggregate Purchase Price purchase price in the amount of at least $800,0005,000,000. Any officer or director of the Company or the Placement Agent, or any of such parties affiliates, may participate in this offering and their investment, if any, will count towards the foregoing minimum amount. As such, Buyer understands that the Company may not receive proceeds hereunder in any amount greater than $800,00012,500,000 (including an over-allotment option exercisable by the Placement Agent for the Company to sell up to an additional $2,500,000 of Units), which may limit the Company’s ability to execute upon its intended business plan.
Appears in 1 contract
Samples: Securities Purchase Agreement (Ondas Holdings Inc.)
Minimum Offering. Each Buyer understands that the Company may accept such Buyer’s purchase hereunder, at any time once the Company shall have received an aggregate Purchase Price purchase price in the amount of at least $800,0002,000,000. Any officer or director of the Company or the Placement Agent, or any of such parties affiliates, may participate in this offering and their investment, if any, will count towards the foregoing minimum amount. As such, Buyer understands that the Company may not receive proceeds hereunder in any amount greater than $800,0002,000,000, which may limit the Company’s ability to execute upon its intended business plan.
Appears in 1 contract
Samples: Securities Purchase Agreement (ENDRA Life Sciences Inc.)
Minimum Offering. Each The Buyer understands that the Company may accept such Buyer’s purchase of Units hereunder, at any time once the Company shall have received an aggregate Purchase Price in the amount of $800,0005 million. Any officer or director of the Company or the Placement Agent, or any of such parties affiliates, may participate in this offering and their investment, if any, will count towards the foregoing minimum amount. As such, the Buyer understands that the Company may not receive proceeds hereunder in any amount greater than $800,0005 million, which may limit the Company’s ability to execute upon its intended business plan.
Appears in 1 contract
Samples: Securities Purchase Agreement (Imprimis Pharmaceuticals, Inc.)